Rafael
Martínez Monge
Catedrático de Universidad
Miren
Gaztañaga Boronat
Publicaciones en las que colabora con Miren Gaztañaga Boronat (9)
2012
-
Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer
Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088
-
External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome
International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3
-
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial
International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593
-
Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer
Brachytherapy, Vol. 11, Núm. 2, pp. 119-124
2011
-
Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4
-
Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy
International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4
-
Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy
International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163
-
Patterns of response after preoperative treatment in gastric cancer
International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704
2010
-
A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer
International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140